{
    "clinical_study": {
        "@rank": "28394", 
        "brief_summary": {
            "textblock": "Hyperhomocysteinemia is a risk for thrombosis. Thrombosis is more frequent in\n      myeloproliferative neoplasms (MPNs) than the normal population. In this study, we\n      investigated the thrombosis incidence, the effects of plasma homocysteine levels on\n      thrombosis, and the correlations between folate, cobalamin, pyridoxine and homocysteine\n      levels in MPNs, and to compare these results with the healthy controls."
        }, 
        "brief_title": "Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs", 
        "completion_date": {
            "#text": "June 2004", 
            "@type": "Actual"
        }, 
        "condition": "Thrombosis", 
        "condition_browse": {
            "mesh_term": [
                "Myeloproliferative Disorders", 
                "Philadelphia Chromosome", 
                "Thrombosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Thirty-one new or formerly diagnosed MPN patients who consecutively visitted our outpatient\n      clinic, as well as 40 age and sex matched healthy controls were enrolled in this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Adult MPN patients and healthy controls who gave a written consent were included in the\n        study.\n\n        Exclusion Criteria:\n\n        Exclusion criteria included not giving a written consent and using medications without an\n        indication which may have an effect on plasma homocysteine and vitamin levels."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Between January and June 2003, thirty-one new or formerly diagnosed MPN patients who\n        consecutively visitted our clinic, as well as 40 age and sex matched healthy controls were\n        enrolled in this study."
            }
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01878916", 
            "org_study_id": "HcyMPN"
        }, 
        "intervention_browse": {
            "mesh_term": "Vitamins"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "the incidence of thrombosis,", 
            "the effect of Hcy on thrombosis formation,", 
            "the relation between Hcy and plasma vitamin levels,", 
            "to compare these results with the control group"
        ], 
        "lastchanged_date": "June 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Istanbul", 
                    "country": "Turkey"
                }, 
                "name": "Istanbul University Cerrahpasa Medical Faculty"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "Plasma Cobalamin, Folate, Pyridoxine and Homocysteine Levels and Thrombosis in Patients With Philadelphia-chromosome-negative Myeloproliferative Neoplasms", 
        "other_outcome": {
            "measure": "Death", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_official": {
            "affiliation": "Istanbul University", 
            "last_name": "Ahmet Emre Eskazan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2004", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Thrombosis", 
            "safety_issue": "No", 
            "time_frame": "at least 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01878916"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Istanbul University", 
            "investigator_full_name": "Dr. A. Emre E\u015fkazan", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "High Hcy level", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Istanbul University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Istanbul University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2003", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "12 Months", 
        "verification_date": "June 2013"
    }
}